1. Home
  2. GNPX vs LXEH Comparison

GNPX vs LXEH Comparison

Compare GNPX & LXEH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genprex Inc.

GNPX

Genprex Inc.

HOLD

Current Price

$1.76

Market Cap

6.4M

Sector

Health Care

ML Signal

HOLD

Logo Lixiang Education Holding Co. Ltd.

LXEH

Lixiang Education Holding Co. Ltd.

HOLD

Current Price

$0.20

Market Cap

6.5M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNPX
LXEH
Founded
2009
2001
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
6.5M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
GNPX
LXEH
Price
$1.76
$0.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
278.5K
574.2K
Earning Date
05-11-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.18
52 Week High
$12.97
$50.08

Technical Indicators

Market Signals
Indicator
GNPX
LXEH
Relative Strength Index (RSI) 39.18 40.74
Support Level $0.18 $0.19
Resistance Level $2.12 $0.28
Average True Range (ATR) 0.10 0.02
MACD -0.01 -0.00
Stochastic Oscillator 16.15 5.67

Price Performance

Historical Comparison
GNPX
LXEH

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About LXEH Lixiang Education Holding Co. Ltd.

Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.

Share on Social Networks: